Offer - Urjas Oil for just ₹ 1 X
Vasoprin 60 Mg/150 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Vasoprin 60 Mg/150 Tablet safe for pregnant women?
Vasoprin can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Vasoprin 60 Mg/150 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Vasoprin. So it is adviced to consult the doctor before using it.
What is the effect of Vasoprin 60 Mg/150 Tablet on the Kidneys?
Vasoprin may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Vasoprin 60 Mg/150 Tablet on the Liver?
Vasoprin does not damage the liver.
What is the effect of Vasoprin 60 Mg/150 Tablet on the Heart?
There may be an adverse effect on the heart after taking Vasoprin. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Vasoprin 60 Mg/150 Tablet unless your doctor advises you to do so -
Is this Vasoprin 60 Mg/150 Tablet habit forming or addictive?
Vasoprin 60 Mg/150 Tablet does not cause addiction.
Interaction between Food and Vasoprin 60 Mg/150 Tablet
There is no information on the effects of taking Vasoprin 60 Mg/150 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Vasoprin 60 Mg/150 Tablet
Information about the interaction of Vasoprin 60 Mg/150 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; monoket® (isosorbide mononitrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 544
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 716-718
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194